23.08.2023 - Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in the following .
WOODCLIFF LAKE, N.J., Aug. 22, 2023 (GLOBE NEWSWIRE) Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company") today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief
Eagle Pharmaceuticals to Present at Two Upcoming Healthcare Conferences tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Q3 2023 Investor Conference & Events Highlights investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.
At the end of the latest market close, Reata Pharmaceuticals Inc. (RETA) was valued at $26.73. In that particular session, Stock kicked-off at the price of $26.82 while reaching the peak value of $26.9366 and lowest value recorded on the day was $24.60. The stock current value is $24.72.Recently in